National Cervical Screening Programme - reform - Budget 2015-16

From May 2017, the National Cervical Screening Policy will change from 2 yearly pap smears to 5 yearly human papillomavirus (HPV) tests.

This measure is subject to the passage of legislation.

Description of the measure

The target age group for cervical screening will also change from women aged 18 to 69 years to women aged 25 to 74 years.

Questions and answers

Who is affected by this measure

All women eligible for cervical screening under the National Cervical Screening Program (NCSP) will be affected by this measure.

Medicare benefits will be introduced for new pathology services that support the screening and management pathway of the new National Cervical Screening Program. The existing services for cervical screening and management will be removed. Practitioners will bill Medicare for the 5 yearly HPV tests from May 2017.

More information is available from the Cancer Screening website.

Who is eligible for this measure

Women aged 25 to 74 accessing cervical screening services under Medicare could be eligible for this measure.

The date this measure will start and finish

This measure will start on 1 May 2017 and is ongoing.

Page last updated: 5 July 2018